This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignees: The United States of America as Represented by the Department of Health, The United States of America as Represented by the Secretary of, Other. Active years: 1986-1998.
Location History:
- Wheaton, MD (US) (1986)
- Kensington, MD (US) (1989)
- Bethesda, MD (US) (1994 - 1996)
- Albuquerque, NM (US) (1997 - 1998)
Company Filing History:
3 out of 1,217 
3 out of 2,202 
1 out of 834,411 Years Active: 1986-1998
Title: The Innovations of John F. Lechner
Introduction
John F. Lechner is a notable inventor based in Bethesda, MD (US), recognized for his contributions to the field of biomedical research. With a total of 7 patents, he has made significant strides in the development of human liver epithelial cell lines, which have important implications for medical research and drug testing.
Latest Patents
Lechner's latest patents focus on immortalized cell lines derived from normal adult human liver. These cell lines express phenotypic characteristics of normal adult liver epithelial cells. His inventions provide methods for using these immortalized cells to evaluate the cytotoxicity or carcinogenicity of various compounds, thereby advancing the understanding of liver-related health issues.
Career Highlights
Throughout his career, John F. Lechner has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the United States of America as represented by the Secretary of Health. His work has been pivotal in enhancing the methodologies used in biomedical research.
Collaborations
Lechner has collaborated with notable colleagues such as Curtis C. Harris and Roger R. Reddel, contributing to a rich exchange of ideas and innovations in the field.
Conclusion
John F. Lechner's work in developing immortalized human liver epithelial cell lines has made a lasting impact on biomedical research. His patents and collaborations continue to influence the evaluation of compounds for safety and efficacy.